Ning Ren
Ning Ren is the technical director and group leader for the discovery LM BA group at WuXi AppTec’s laboratory testing division in New Jersey, US. Her team provides bioanalytical services for biomarkers and various modalities, including ADCs, oligonucleotides, antibodies and fusion proteins. Prior to joining WuXi AppTec in 2015, she worked at Merck for more than 19 years. She received her degrees from the University of Rochester and Beijing Normal University and is the author or co-author of more than 26 peer-reviewed publications.
ArticleOptimising analytical strategies for ADC development
Antibody-drug conjugates (ADCs) are transforming cancer therapy by enabling targeted drug delivery with minimised side effects, but their complex structure presents unique challenges in bioanalysis.